Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 15c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $78.89 --0%
EPS Growth %: +4.8%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: +4.8%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.60), $0.15 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $47.81 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New leader board: Citi refreshes AI compute semiconductor picks
- Relmada Therapeutics added to Russell 2000 and Russell 3000 indexes
- Applied Materials (AMAT) PT Raised to $850 at Cantor Fitzgerald: Limited EPS Upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
